Company Filing History:
Years Active: 2001-2003
Title: Imre Weisz: Innovator in Anti-Tumorigenic Compounds
Introduction
Imre Weisz is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-tumorigenic properties. With a total of 2 patents to his name, Weisz continues to push the boundaries of innovation in cancer treatment.
Latest Patents
Weisz's latest patents focus on aminobenzoic acid derivatives that exhibit anti-tumorigenic activity. These patents detail the synthesis and application of haloacetoamido, benzoic acid derivatives, which include various examples such as 3-chloroacetoamido, benzoylurea, and ethyl-3-iodoacetoamido, benzoate. The inventions provide methods for making and utilizing these derivatives, showcasing their potential in cancer therapy.
Career Highlights
Imre Weisz is affiliated with the Mount Sinai School of Medicine, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on cancer treatment, making him a key figure in his area of expertise.
Collaborations
Weisz has collaborated with esteemed colleagues, including George J Bekesi and Jian-Dong Jiang. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Imre Weisz stands out as an influential inventor in the realm of anti-tumorigenic compounds. His innovative work at the Mount Sinai School of Medicine continues to pave the way for advancements in cancer treatment.